A team of German scientists and biotech company Dynamic42 have jointly developed a ‘tumour-on-chip’ model of pancreatic ductal adenocarcinoma (PDAC), allowing insights into interactions ...

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...

Andersson-Rolf’s experiments, published in Cell, identified a stem cell that differentiates into the three cell types, enabling the researchers to create an organoid that mimicked the fetal pancreas.

Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept pancreatic cancer at bay in preclinical models for significantly longer ...

Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ...

Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ...

In a study published in ACS Nano, experiments in lab models demonstrated that the nanoparticle both inhibited and prevented the growth of pancreatic cancer in the liver. Importantly, it also ...

In a study newly published in ACS Nano, experiments in lab models demonstrated that the nanoparticle both inhibited and prevented the growth of pancreatic cancer in the liver. Importantly ...

(RTTNews) - Silexion Therapeutics (SLXN) announced positive data from preclinical studies of SIL204, its RNA interference (RNAi) therapy, in orthotopic pancreatic cancer models. These findings ...

Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ...